Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and β-lactamase producing Klebsiella pneumoniae

References

• Arnold RS, Thom KA, Sharma S, et al. (2011). Emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. South Med J 104:40–5
   PubMed Web of Science ®Google Scholar
• Baell JB, Holloway GA. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719–40
   PubMed Web of Science ®Google Scholar
• Biswas T, Resto-Roldán E, Sawyer SK, et al. (2013). A novel non-radioactive primase–pyrophosphatase activity assay and its application to the discovery of inhibitors of Mycobacterium tuberculosis primase DnaG. Nucleic Acids Res 41:e56
   Google Scholar
• Clinical and Laboratory Standards Institute. (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Third Informational Supplement. Wayne: CLSI
   Google Scholar
• Cockerill FR III. (1998). Conventional and genetic laboratory tests used to guide antimicrobial therapy. Mayo Clin Proc 73:1007–21
   PubMedGoogle Scholar
• Collee JG, Fraser AG, Marmion BP, Simmons A. eds. (1996). Mackie and McCartney Practical Medical Microbiology. London: Churchill Livingstone
   Google Scholar
• Correa L, Martino MD, Siqueira I, et al. (2013). A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis 13:80
   PubMed Web of Science ®Google Scholar
• Dai J, Mumper RJ. (2010). Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules 15:7313–52
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. (2010). Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–33
   PubMed Web of Science ®Google Scholar
• Dey D, Debnath S, Hazra S, et al. (2012). Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL) producing Gram negative bacilli. Food Chem Toxicol 50:4302–9
   PubMed Web of Science ®Google Scholar
• Dey D, Ray R, Hazra B. (2014). Antitubercular and antibacterial activity of quinonoid natural products against multi-drug resistant clinical isolates. Phytother Res. 28:1014–21
   Google Scholar
• Glaser J, Schultheis M, Hazra S, et al. (2014). Antileishmanial lead structures from nature: Analysis of structure-activity relationships of a compound library derived from caffeic acid bornyl ester. Molecules 19:1394–410
   PubMed Web of Science ®Google Scholar
• Gradisar H, Pristovsek P, Plaper A, Jerala R. (2007). Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem 50:264–71
   PubMed Web of Science ®Google Scholar
• Jurenka J. (2008). Therapeutic applications of pomegranate (Punica granatam L.): Review. Altern Med Rev 13:128–44
   PubMed Web of Science ®Google Scholar
• Kang C-I, Song J-H. (2013). Antimicrobial resistance in Asia: Current epidemiology and clinical implications. Infect Chemother 45:22–31
   PubMedGoogle Scholar
• Knothe H, Shah P, Krcmery V, et al. (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315–17
   PubMed Web of Science ®Google Scholar
• Kolyva AS, Karakousis PC. (2012). Old and new TB drugs: Mechanisms of action and resistance. In: Cardona P-J, ed. Understanding Tuberculosis – New Approaches to Fighting Against Drug Resistance. Europe: InTech, 209–32
   Google Scholar
• Naz S, Siddiqi R, Ahmad S, et al. (2007). Antibacterial activity directed isolation of compounds from Punica granatum. J Food Sci 72:341–5
   PubMed Web of Science ®Google Scholar
• Plaper A, Golob M, Hafner I, et al. (2003). Characterisation of quercetin binding site on DNA gyrase. Biochem Biophys Res Commun 306:530–6
   PubMed Web of Science ®Google Scholar
• Scalbert A, Manach C, Morand C, et al. (2005). Polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306
   PubMed Web of Science ®Google Scholar
• Sharma SK, Kumar G, Kapoor M, Surolia A. (2008). Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochem Biophys Res Commun 368:12–17
   PubMed Web of Science ®Google Scholar
• Silva T, Oliveira C, Borges F. (2014). Caffeic acid derivatives, analogs and applications: A patent review (2009–2013). Expert Opin Ther Pat 24:1257–70
   PubMed Web of Science ®Google Scholar
• Suriyanarayanan B, Shanmugam K, Santhosh RS. (2013). Synthetic quercetin inhibits mycobacterial growth possibly by interacting with DNA gyrase. Rom Biotechnol Lett 18:1587–93
   Google Scholar
• Wong SY, Grant IR, Friedman M, et al. (2008). Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl Environ Microbiol 74:5986–90
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2012). Global tuberculosis report (WHO/HTM/TB/2012.6.). Geneva, Switzerland: WHO [Online]. Available from: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf [last accessed 17 Nov 2014]
   Google Scholar
• Zhang YM, Rock CO. (2004). Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 279:30994–1001
   PubMed Web of Science ®Google Scholar